Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Infusion system recalled for possible leaks after multiple complaints

The recall includes more than 1,500 devices distributed to customers from October 2021 to January 2023. 

Thumbnail

OTC Narcan will cost less than $50

The drug's manufacturer said it is working with retailers to get the drug on U.S. shelves and online for purchase by late summer.

Thumbnail

American College of Cardiology shares new HFpEF recommendations as cases continue to rise

HFpEF now accounts for a majority of heart failure cases, highlighting the importance of ensuring both primary care providers and dedicated heart teams know as much about this topic as possible. 

Thumbnail

Radiology provider Envision Healthcare considers handing control to creditors in bankruptcy

The multispecialty group—which employs about 500 radiologists—is exploring chapter 11 as it grapples with a heavy debt load. 

How the FDA’s approval process puts the safety of heart patients at risk

After high-risk medical devices go through the initial FDA approval process, it is relatively easy for manufacturers to get updates to those devices approved. New evidence suggests that this policy could be leading to more recalls, especially among cardiovascular devices.  

COVID-19 congress coronavirus Washington

Radiology among 120 medical societies announcing support for ‘broken’ Medicare pay system fix

“Organized medicine is united in support of a long-term payment solution," numerous national and state societies wrote to members of Congress. 

Thumbnail

Judge halts all lawsuits related to J&J talc formula

A U.S. judge halted all lawsuits against Johnson & Johnson over allegations that its talc formula products and baby powder contained cancer-causing asbestos, stopping any trials as the company has agreed to settle all claims for billions of dollars.

DOJ targets COVID-related healthcare fraud

One official described it as the 'largest-ever coordinated law enforcement action' of its kind.